Kevin T.  Conroy net worth and biography

Kevin Conroy Biography and Net Worth

Kevin Conroy is the Chief Executive Officer, President, and Chairman of the Board of Exact Sciences. He became CEO 11 years ago and he has been part of a team that transformed Exact Sciences into one of the world’s premier cancer diagnostics companies with more than 4,500 employees.

Mr. Conroy has led Exact Sciences through the development, clinical trial, regulatory approval, and commercialization of its noninvasive colorectal cancer screening test, Cologuard®. This culminated with Cologuard becoming the first medical device or diagnostic to receive simultaneous FDA approval and national Medicare coverage. Since 2014, millions of Americans have used Cologuard to screen for colorectal cancer, the second leading cause of cancer death in the United States.

In 2019, Exact Sciences’ acquisition of Genomic Health, Inc., united two of the industry’s strongest brands, Cologuard and Oncotype DX®, and established the company’s position as the global leader in advanced cancer diagnostics. The global company is working to improve screening, early detection, and treatment guidance throughout the cancer continuum.

Before joining Exact Sciences, Mr. Conroy served as CEO and President of Third Wave Technologies, a molecular diagnostics company that developed a breakthrough cervical cancer screening test before being acquired by Hologic in 2008. Mr. Conroy also held leadership positions at GE Healthcare, a global leader in medical imaging and information technology, and practiced intellectual property law in private practice. Mr. Conroy currently serves as a director of Epizyme, Inc. and Adaptive Biotechnology Corporation.

Mr. Conroy is active in the Wisconsin community. He serves as a director of the Greater Madison Chamber of Commerce and on the University of Wisconsin-Madison Chancellor’s Advisory Council. He has also served as chair of The United Way of Dane County’s 2016 annual campaign and as a board member of Overture Center for the Arts.

A native of Flint, Michigan, Mr. Conroy holds a Bachelor of Science degree in electrical engineering from Michigan State University and earned his Juris Doctorate from the University of Michigan Law School.

What is Kevin T. Conroy's net worth?

The estimated net worth of Kevin T. Conroy is at least $46.90 million as of November 13th, 2024. Mr. Conroy owns 1,074,191 shares of Exact Sciences stock worth more than $46,899,179 as of March 29th. This net worth estimate does not reflect any other investments that Mr. Conroy may own. Additionally, Mr. Conroy receives a salary of $3,140,000.00 as CEO at Exact Sciences. Learn More about Kevin T. Conroy's net worth.

How old is Kevin T. Conroy?

Mr. Conroy is currently 58 years old. There are 6 older executives and no younger executives at Exact Sciences. Learn More on Kevin T. Conroy's age.

What is Kevin T. Conroy's salary?

As the CEO of Exact Sciences Co., Mr. Conroy earns $3,140,000.00 per year. Learn More on Kevin T. Conroy's salary.

How do I contact Kevin T. Conroy?

The corporate mailing address for Mr. Conroy and other Exact Sciences executives is 5505 ENDEAVOR LANE, MADISON WI, 53719. Exact Sciences can also be reached via phone at (608) 284-5700 and via email at meganjones@exactsciences.com. Learn More on Kevin T. Conroy's contact information.

Has Kevin T. Conroy been buying or selling shares of Exact Sciences?

Kevin T. Conroy has not been actively trading shares of Exact Sciences over the course of the past ninety days. Most recently, on Wednesday, November 13th, Kevin T. Conroy bought 19,500 shares of Exact Sciences stock. The stock was acquired at an average cost of $51.35 per share, with a total value of $1,001,325.00. Following the completion of the transaction, the chief executive officer now directly owns 1,074,191 shares of the company's stock, valued at $55,159,707.85. Learn More on Kevin T. Conroy's trading history.

Who are Exact Sciences' active insiders?

Exact Sciences' insider roster includes Brian Baranick (Insider), Sarah Condella (SVP), Kevin Conroy (CEO), D. Coward (Insider), Everett Cunningham (Insider), James Doyle (Director), Jeffrey Elliott (CFO), James Herriott (General Counsel), Torsten Hoof (Insider), Daniel Levangie (Director), Graham Lidgard (Insider), Jacob Orville (Insider), and Katherine Zanotti (Director). Learn More on Exact Sciences' active insiders.

Are insiders buying or selling shares of Exact Sciences?

In the last twelve months, Exact Sciences insiders bought shares 1 times. They purchased a total of 19,500 shares worth more than $1,001,325.00. In the last twelve months, insiders at the medical research company sold shares 8 times. They sold a total of 5,356 shares worth more than $360,164.70. The most recent insider tranaction occured on November, 13th when CEO Kevin T Conroy bought 19,500 shares worth more than $1,001,325.00. Insiders at Exact Sciences own 1.4% of the company. Learn More about insider trades at Exact Sciences.

Information on this page was last updated on 11/13/2024.

Kevin T. Conroy Insider Trading History at Exact Sciences

Kevin T. Conroy Buying and Selling Activity at Exact Sciences

This chart shows Kevin T Conroy's buying and selling at Exact Sciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$2M-$1M$0$1M$2MTotal Insider BuyingTotal Insider Selling

Exact Sciences Company Overview

Exact Sciences logo
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX Breast Recurrence Score Test; Oncotype DX Breast DCIS Score Test; Oncotype DX Colon Recurrence Score Test; OncoExTra Test for tumor profiling for patients with advanced, metastatic, refractory, relapsed, or recurrent cancer; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research, and Johns Hopkins University. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.
Read More

Today's Range

Now: $43.66
Low: $43.55
High: $44.98

50 Day Range

MA: $49.71
Low: $43.04
High: $56.05

2 Week Range

Now: $43.66
Low: $40.62
High: $79.62

Volume

1,336,419 shs

Average Volume

2,626,482 shs

Market Capitalization

$8.11 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.25